Medical Science and Healthcare

73 Articles in this topic
Tech & Science

Koya-dofu: Japanese Freeze-Dried Tofu Shows Promise for Obesity Prevention | Shinshu University Research Reveals GLP-1 Boosting Effects

Groundbreaking research from Shinshu University and Asahimatsu Foods reveals that koya-dofu (freeze-dried tofu), a traditional Japanese preserved food, contains resistant protein that promotes GLP-1 production, potentially preventing obesity and fatty liver disease. Discover why the world is turning to Japanese fermented and preserved foods for health benefits.

All73 stories in Medical Science and Healthcare

Newest first
Tech & Science

20 Years of iPS Cells: Japan Leads Race for World's First Regenerative Medicine Approval in 2026

Marking 20 years since Professor Shinya Yamanaka's groundbreaking iPS cell discovery, Japan advances toward world-first regulatory approval of regenerative medicine products in 2026. Explore the latest clinical trials for Parkinson's disease treatment and heart failure therapy, and discover how this Japanese innovation is revolutionizing global medicine.

Life & Lifestyle

Japan Moves Toward First Pig-to-Human Organ Transplant Clinical Trials in 2027—Could Xenotransplantation Solve the Donor Crisis?

Japanese startup Pormedtec targets 2027 for Japan's first pig-to-human organ transplant trials. With only 4% of 16,000 registered transplant candidates receiving organs annually, xenotransplantation offers hope. US trials show gene-edited pig kidneys functioning over 7 months in human patients. Will this breakthrough transform Japan's organ shortage crisis?

Tech & Science

Revolutionary Cancer Drug Surv.m-CRA from Kagoshima University Enters Final Trials | First New Bone Tumor Drug in 30 Years

Kagoshima University's oncolytic virus "Surv.m-CRA-1" enters final clinical trials for primary malignant bone tumors. This revolutionary treatment can eliminate cancer stem cells resistant to conventional therapies, offering new hope for bone cancer patients who haven't seen a new drug in over 30 years. Learn about Japan's next-generation cancer therapy targeting 2027 approval.